English | Español

Arena Pharmaceuticals
Cheyenne Dickerson | May 21, 2017

Arena Pharmaceuticals preparing to present ralinepag drug Phase 1 results

Carol Ostrow | Feb 16, 2017

Arena presenting latest data on ulcerative colitis drug at summit
Carol Ostrow | Jan 13, 2017

Eisai acquires rights to Lorcaserin HCI for weight control
Jeff Gantt | Dec 24, 2016

ANVISA approves Belviq in Brazil
Carol Ostrow | Dec 16, 2016

Arena Pharmaceuticals plans Jan. 12 webcast, conference presentation

Jeff Gantt | Dec 14, 2016

Arena finalizes enrollment in ralinepag trial
Amanda Rupp | May 26, 2016

Arena Pharmaceuticals welcomes new president, CEO

Trending
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval